| 1 |
12048068 | Enhanced GLUT2 gene expression in an oleic acid-induced in vitro fatty liver model. | 2002 Jun |
1 |
| 2 |
10751747 | Pravastatin compared to bezafibrate in the treatment of dyslipidemia in insulin-treated patients with type 2 diabetes mellitus. | 2000 Mar-Apr |
1 |
| 3 |
11426588 | Effect of bezafibrate or pravastatin on serum lipid levels and albuminuria in NIDDM patients. | 2000 |
1 |
| 4 |
9607127 | Comparison of the effect of bezafibrate on improvement of atherogenic lipoproteins in Japanese familial combined hyperlipidemic patients with or without impaired glucose tolerance. | 1998 Mar |
1 |
| 5 |
9822092 | Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT). | 1998 Nov 15 |
1 |
| 6 |
1397477 | Comparison of the effects of bezafibrate and acipimox on the lipid pattern and plasma fibrinogen in hyperlipidaemic type 2 (non-insulin-dependent) diabetic patients. | 1992 May-Jun |
1 |
| 7 |
1596293 | Hypolipidemic drugs reduce lipoprotein susceptibility to undergo lipid peroxidation: in vitro and ex vivo studies. | 1992 Mar |
1 |
| 8 |
2360915 | Interruption of long-term lipid-lowering treatment with bezafibrate in hypertriglyceridaemic patients. Effects on lipoprotein composition, lipase activities and the plasma lipid fatty acid spectrum. | 1990 May |
1 |
| 9 |
2894548 | Comparison between simvastatin and bezafibrate in effect on plasma lipoproteins and apolipoproteins in primary hypercholesterolaemia. | 1988 Mar 19 |
1 |
| 10 |
3884023 | [Statistical analysis of variations in total cholesterol, HDL, HDL2, HDL3, LDL-cholesterol, VLDL-triglycerides, apo-A and apo-B lipoproteins in dyslipidemias during antilipemic therapy]. | 1985 Jan 30 |
1 |